share_log

荣昌生物(09995.HK)拟8月16日举行董事会会议批准中期业绩

Remegen (09995.HK) is planning to hold a board of directors meeting on August 16 to approve the mid-term performance.

Gelonghui Finance ·  Aug 6 04:38

Remegen (09995.HK) announced that the Board of Directors will hold a meeting on Friday, August 16, 2024 to consider and approve the interim performance of the company and its subsidiaries, ending on June 30, 2024.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment